A Szállaśi
Researcher Next ID · RN-034602
Researcher · Arts and Humanities
Budapest, Sweden
- Works count
- 512
- Citation count
- 14,125
- H-index
- 55
- i10-index
- 126
Research interests
Publications
Advances in TRP channel drug discovery: from target validation to clinical studies
Nature Reviews Drug Discovery · 2021 · https://doi.org/10.1038/s41573-021-00268-4
Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field
British Journal of Pharmacology · 2017 · https://doi.org/10.1111/bph.14044
Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine
Pharmacological Reviews · 2014 · https://doi.org/10.1124/pr.113.008268
Targeting TRP channels for pain relief
European Journal of Pharmacology · 2013 · https://doi.org/10.1016/j.ejphar.2013.03.003
Transient receptor potential ( TRP ) channels: a clinical perspective
British Journal of Pharmacology · 2013 · https://doi.org/10.1111/bph.12414
Transient receptor potential channels as therapeutic targets
Nature Reviews Drug Discovery · 2011 · https://doi.org/10.1038/nrd3456
Capsaicin (TRPV1 Agonist) Therapy for Pain Relief
Clinical Journal of Pain · 2008 · https://doi.org/10.1097/ajp.0b013e318158ed9e
Peripheral TRPV1 Receptors As Targets for Drug Development: New Molecules and Mechanisms
Current Pharmaceutical Design · 2008 · https://doi.org/10.2174/138161208783330754
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Nature Reviews Drug Discovery · 2007 · https://doi.org/10.1038/nrd2280
The emerging role of TRPV1 in diabetes and obesity
Trends in Pharmacological Sciences · 2007 · https://doi.org/10.1016/j.tips.2007.10.016
TRPV1: a therapeutic target for novel analgesic drugs?
Trends in Molecular Medicine · 2006 · https://doi.org/10.1016/j.molmed.2006.09.001
Biochemical pharmacology of the vanilloid receptor TRPV1
European Journal of Biochemistry · 2004 · https://doi.org/10.1111/j.1432-1033.2004.04082.x
Vanilloid (Capsaicin) Receptors in Health and Disease
American Journal of Clinical Pathology · 2002 · https://doi.org/10.1309/7ayy-vvh1-gqt5-j4r2
New perspectives on enigmatic vanilloid receptors
Trends in Neurosciences · 2000 · https://doi.org/10.1016/s0166-2236(00)01630-1
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human
Proceedings of the National Academy of Sciences · 2000 · https://doi.org/10.1073/pnas.97.7.3655
Vanilloid (Capsaicin) Receptors and Mechanisms
Pharmacological Reviews · 1999 · https://doi.org/10.1016/s0031-6997(24)01403-0
Euphorbium: Modern research on its active principle, resiniferatoxin, revives an ancient medicine
Life Sciences · 1997 · https://doi.org/10.1016/s0024-3205(96)00567-x
Vanilloid receptors: new insights enhance potential as a therapeutic target
Pain · 1996 · https://doi.org/10.1016/s0304-3959(96)03202-2
Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment
Brain Research · 1995 · https://doi.org/10.1016/0006-8993(95)01094-7
The vanilloid (capsaicin) receptor: Receptor types and species differences
General Pharmacology The Vascular System · 1994 · https://doi.org/10.1016/0306-3623(94)90049-3
Resiniferatoxin and its analogs provide novel insights into the pharmacology of the vanilloid (capsaicin) receptor
Life Sciences · 1990 · https://doi.org/10.1016/0024-3205(90)90518-v
Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root anglion membranes
Brain Research · 1990 · https://doi.org/10.1016/0006-8993(90)90498-z
Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper
Neuroscience · 1989 · https://doi.org/10.1016/0306-4522(89)90269-8
Current projects
No projects listed.